The Rise of Mitochondrial-Targeted Peptides In 2026, mitochondrial dysfunction is increasingly recognized as a central driver of cellular aging, metabolic disorders, and degenerative diseases. Among the most significant breakthroughs in this field is SS-31, also known as elamipretide. Unlike traditional antioxidants that scavenge free radicals indiscriminately, SS-31 specifically targets the inner mitochondrial membrane, marking a […]
